Japan ranks third globally in pharmaceutical market. Industry value reached $105 billion in 2019. Pharmaceutical production amounted to 9.3 trillion yen in 2020. Most production is prescription drugs
Medical affairs evolved from commercial sub-teams supporting physician inquiries. Traditional roles included medical publications and field interactions. Regulatory scrutiny forced separation from commercial operations
Eisai is a Japanese pharmaceutical company headquartered in Tokyo. Company has approximately 10,000 employees, including 1,500 in research. Listed on Tokyo Stock Exchange and operates in Topix 100 and Nikkei 225
Family-owned German pharmaceutical company headquartered in Frankfurt. Employs around 3,730 people with EUR 1.3434 billion revenue in 2021/22. Current management includes Philip Burchard as CEO and Hans-Jörg Bergler as COO
International generic pharmaceutical company based in Novo Mesto, Slovenia. Generated 1.806 billion euros in sales in 2023. Employed 12,753 people as of 2023. Operates in over 70 countries worldwide
Teva is an Israeli multinational pharmaceutical company specializing in generic drugs. Listed on Tel Aviv and New York Stock Exchanges. Largest generic drug manufacturer globally. Operates facilities in Israel, North America, Europe, Australia and South America